Zixing Wang

Zixing Wang

Auto-generated profile, based on publicly available information

Zixing Wang

Peking University People’s Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center of Peking University People’s Hospital, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

28 September 2024 in Helicobacter
Verified
Journal Article
Closed access
ZWZixing Wang
Zixing Wang
YHYaoda Hu
Yaoda Hu
RFRan Fei
Ran Fei
WHWei Han
Wei Han
XWXiaoxiao Wang
Xiaoxiao Wang
SSShaoping She
Shaoping She

8 July 2023 in npj Clean Water
Verified
Journal Article
Open access
PDF file
ZWZixing Wang
Zixing Wang
WGWentao Gu
Wentao Gu
XGXiaobo Guo
Xiaobo Guo
FXFang Xue
Fang Xue
JZJing Zhao
Jing Zhao
JJJingmei Jiang
Jingmei Jiang
Little is known about the association between surface water quality and cancer incidence, especially in China. Drinking water quality has been linked to the incidence of several cancers in individual-level studies. However, few studies have attempted to examine multiple pollutants and multiple cancers at population level. This study used water monitoring and population-level cancer data from across China to examine spatial associations between water pollutants and types of cancer. We found a “dose–response” relationship between the number of pollutants present at high levels and cancer incidence. These results provide evidence of a nationwide spatial association between water quality and cancer in China. The precise relationship varies with cancers and pollutants. However, the overall consistency of the “dose–response” relationship suggests that surface water quality is an important factor in cancer incidence. Our findings highlight new issues such as the changing effects when different pollutants co-exist and an increasing number of new cancer cases partially attributable to poor water quality. Our work also points to some ways to deal with these challenges.

30 December 2024 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ZWZixing Wang
Zixing Wang
WHWei Han
Wei Han
RFRan Fei
Ran Fei
YHYaoda Hu
Yaoda Hu
FXFang Xue
Fang Xue
JJJingmei Jiang
Jingmei Jiang
The colorectal cancer mortality rate in China has exceeded that in many developing countries and is expected to further increase owing to multiple factors, including the aging population. However, the optimal policy for colorectal cancer screening is unknown. We synthesized the most up-to-date data using a 12-state Markov model populated with a cohort of Chinese men and women born during 1949–1988, and evaluated 16 conventional and 40 risk-tailored schemes for colorectal cancer screening, considering possible combinations of age (starting at 40 + years and ending at 75 years), frequency, and strategy (standard colonoscopy, fecal immunochemical testing with colonoscopy if positive, or risk-tailored). We projected the incidence and mortality of CRC, cost, and quality-adjusted life years for 2023–2038; and performed incremental cost-effectiveness, probability acceptability, and sensitivity analyses to identify the optimal scheme and the factors affecting this choice. By 2038, all standard colonoscopy, colonoscopy following fecal immunochemical testing, and risk-tailored schemes were effective in reshaping China’s colorectal cancer trajectory, with relative reductions in colorectal cancer incidence and mortality rates of up to 34% and 33.7%, respectively, versus no screening. Two standard colonoscopy, one colonoscopy following fecal immunochemical testing, and four risk-tailored schemes were efficient using a starting age of 40 years. Among these options, a risk-tailored scheme (standard colonoscopy every 5 years for high-risk and annual fecal immunochemical testing screening for moderate-to-low-risk) had a high probability (31.1%) of being optimal (with ≥ 40% uptake for a high-risk population, in particular), given China’s present per capita gross domestic product, and would yield the highest gain in quality-adjusted life years in 17 of 31 provinces. Our findings suggest the commencement of colorectal cancer screening at 40 years of age in China, and that risk-tailored and some conventional schemes would be effective and cost-efficient. These findings should be valuable for policy-making regarding cancer control and resource allocation.

24 June 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
XYXiaochu Yu
Xiaochu Yu
WHWei Han
Wei Han
JJJingmei Jiang
Jingmei Jiang
YWYipeng Wang
Yipeng Wang
SXShijie Xin
Shijie Xin
YZYupei Zhao
Yupei Zhao
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Several large surgical complication reporting systems and system-based interventions have been developed and have made remarkable progress in the past two decades. However, these have either mainly focused on reporting complications, and played a limited role in guiding practice, or have provided non-selective interventions to all patients, perhaps imposing unnecessary burdens on frontline medical staff. We have therefore developed an evidence-based stratified surgical safety information system based on a multi-center surgical safety improvement program. This article discusses some critical issues in the process of developing this information system, including (1) decisions about data gathering; (2) establishing and sharing knowledge; (3) developing functions for the system; (4) system implementation; and (5) evaluation and continuous improvement. Using examples drawn from above mentioned surgical safety improvement program, we have shown how this type of system can be fitted into day-to-day clinical practice and how it can guide medical practice by incorporating inherent patient-related risk, and providing tailored interventions for patients with different levels of risk. We concluded that multidisciplinary collaboration, including experts in the fields of healthcare (including senior staff in surgery, nursing and anesthesia), data science, healthcare management and health IT, can help to build an evidence-based stratified surgical patient safety improvement system. This can provide an information-intensified surgical safety learning platform and therefore benefit surgical patients by delivering tailored interventions, and an integrated workflow.

1 July 2024 in Cancer Medicine
Verified
Journal Article
Open access
ZWZixing Wang
Zixing Wang
XSXin Sui
Xin Sui
WSWei Song
Wei Song
FXFang Xue
Fang Xue
WHWei Han
Wei Han
JJJingmei Jiang
Jingmei Jiang
Background: The current guidelines for managing screen‐detected pulmonary nodules offer rule‐based recommendations for immediate diagnostic work‐up or follow‐up at intervals of 3, 6, or 12 months. Customized visit plans are lacking.Purpose: To develop individualized screening schedules using reinforcement learning (RL) and evaluate the effectiveness of RL‐based policy models.Methods: Using a nested case–control design, we retrospectively identified 308 patients with cancer who had positive screening results in at least two screening rounds in the National Lung Screening Trial. We established a control group that included cancer‐free patients with nodules, matched (1:1) according to the year of cancer diagnosis. By generating 10,164 sequence decision episodes, we trained RL‐based policy models, incorporating nodule diameter alone, combined with nodule appearance (attenuation and margin) and/or patient information (age, sex, smoking status, pack‐years, and family history). We calculated rates of misdiagnosis, missed diagnosis, and delayed diagnosis, and compared the performance of RL‐based policy models with rule‐based follow‐up protocols (National Comprehensive Cancer Network guideline; China Guideline for the Screening and Early Detection of Lung Cancer).Results: We identified significant interactions between certain variables (e.g., nodule shape and patient smoking pack‐years, beyond those considered in guideline protocols) and the selection of follow‐up testing intervals, thereby impacting the quality of the decision sequence. In validation, one RL‐based policy model achieved rates of 12.3% for misdiagnosis, 9.7% for missed diagnosis, and 11.7% for delayed diagnosis. Compared with the two rule‐based protocols, the three best‐performing RL‐based policy models consistently demonstrated optimal performance for specific patient subgroups based on disease characteristics (benign or malignant), nodule phenotypes (size, shape, and attenuation), and individual attributes.Conclusions: This study highlights the potential of using an RL‐based approach that is both clinically interpretable and performance‐robust to develop personalized lung cancer screening schedules. Our findings present opportunities for enhancing the current cancer screening system.